(Q40437701)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17909728%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

A phase II trial of doxorubicin and interferon alpha 2b in advanced, non-medullary thyroid cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17909728%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

main subject

phase II clinical trial

0 references

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17909728%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Athanassios Argiris

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17909728%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Sanjiv S Agarwala

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17909728%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Michalis V Karamouzis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17909728%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Sally E Carty

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17909728%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

language of work or name

1 reference

2 October 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17909728%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17909728%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17909728%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17909728%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

183-188

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17909728%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10637-007-9091-2

8 January 2020

exact match

0 references

cites work

Thyroid cancer: a lethal endocrine neoplasm

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10637-007-9091-2

Phase I study of recombinant leukocyte A interferon (IFN-alpha 2A, Roferon-A) with doxorubicin in advanced malignant disease

21 January 2018

1 reference

12 December 2020

Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review

1 reference

12 December 2020

Controversies in the surveillance of patients with well differentiated thyroid cancer

1 reference

12 December 2020

Treatment of locally advanced thyroid carcinoma with combination doxorubicin and radiation therapy

1 reference

12 December 2020

Overview of preclinical and clinical studies of interferon alfa-2b in combination with cytotoxic drugs.

1 reference

12 December 2020

Diagnostic value of a single serum thyroglobulin determination on and off thyroid suppressive therapy in the follow-up of patients with differentiated thyroid cancer

1 reference

12 December 2020

Interferon alpha and doxorubicin in malignant mesothelioma: a phase II study

1 reference

12 December 2020

Anaplastic giant cell carcinoma of the thyroid gland: treatment and survival over a 25-year period

1 reference

12 December 2020

Combined recombinant human interferon alpha 2 and cytotoxic agents studied in a clonogenic assay

1 reference

12 December 2020

Combination chemotherapy of advanced medullary and differentiated thyroid cancer. Phase II study

1 reference

12 December 2020

MUC1 oncoprotein promotes refractoriness to chemotherapy in thyroid cancer cells

1 reference

12 December 2020

Phase II study of combination doxorubicin, interferon-alpha, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma

1 reference

12 December 2020

Phase I trial of escalating dose doxorubicin administered concurrently with alpha 2-interferon.

1 reference

12 December 2020

Interferons in the treatment of solid tumors

1 reference

12 December 2020

Anaplastic thyroid carcinoma: an overview

1 reference

12 December 2020

Treatment of advanced medullary thyroid carcinoma with a combination of recombinant interferon alpha-2b and octreotide

1 reference

12 December 2020

Pulmonary metastasis of differentiated thyroid carcinoma: treatment results in 101 patients

1 reference

12 December 2020

Type I interferons modulate the expression of thyroid peroxidase, sodium/iodide symporter, and thyroglobulin genes in primary human thyrocyte cultures.

1 reference

12 December 2020

Chemotherapy for thyroid cancer

1 reference

12 December 2020

Immunoendocrine therapy with low-dose subcutaneous interleukin-2 plus melatonin of locally advanced or metastatic endocrine tumors

1 reference

12 December 2020

Impaired cell-mediated immunity function in thyroid cancer

1 reference

12 December 2020

Phase I study of alpha 2-interferon plus doxorubicin in patients with solid tumors

1 reference

12 December 2020

Reporting results of cancer treatment

1 reference

12 December 2020

Divergent effects of cytokines on human leukocyte antigen-DR antigen expression of neoplastic and non-neoplastic human thyroid cells

1 reference

12 December 2020

Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome

1 reference

12 December 2020

Management and outcome of recurrent well-differentiated thyroid carcinoma

1 reference

12 December 2020

A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma.

1 reference

12 December 2020

Phase II evaluation of doxorubicin plus cisplatin in advanced thyroid cancer: a Southeastern Cancer Study Group Trial

1 reference

12 December 2020

Cancer statistics, 2007

1 reference

12 December 2020